Publication: The Innovative Medicines Initiative: A European Response to the Innovation Challenge

The Innovative Medicines Initiative (IMI) was launched in 2008 as a large-scale public–private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). With a total budget of €2 billion, the IMI aims to boost the development of new medicines across Europe by implementing new…

IMI Newsletter 4

Contents: Save the date! 4th Call Open Info Day, Brussels, 17 June 4th Call topic webinars 4th Call countdown Stakeholder Forum 2011 a success Michel Goldman on IMI’s experiences in Nature Reviews Drug Discovery New IMI publications now out News from the projects IMI presentations at forthcoming conferences View newsletter